Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling

Knowledge gaps that limit the development of therapies for polycystic ovary syndrome (PCOS) concern various environmental factors that impact clinical characteristics. Circadian dysrhythmia contributes to glycometabolic and reproductive hallmarks of PCOS. Here, we illustrated the amelioration of Lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shang, Zhai, Junyu, Chu, Weiwei, Geng, Xueying, Wang, Dongshuang, Jiao, Luwei, Lu, Gang, Chan, Wai-Yee, Sun, Kang, Sun, Yun, Chen, Zi-Jiang, Du, Yanzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329655/
https://www.ncbi.nlm.nih.gov/pubmed/37422471
http://dx.doi.org/10.1038/s41522-023-00415-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329655/
https://www.ncbi.nlm.nih.gov/pubmed/37422471
http://dx.doi.org/10.1038/s41522-023-00415-2

Ejemplares similares